Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month


Recommendation Rating







1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 100.38

Low: 90

High: 117

Total Analysts: 5

Company Profile

DaVita Inc. is a healthcare provider. The Company provides kidney care services in the United States. The Company’s operations are comprised of its U.S. dialysis and related lab services business (U.S. dialysis business), its U.S. ancillary services and strategic initiatives, its international operations (ancillary services), and corporate administrative support. The U.S. dialysis business treats patients with chronic kidney failure, and end-stage kidney disease (ESKD). The Company provides dialysis and administrative services and related laboratory services. Its services include outpatient hemodialysis services, hospital inpatient hemodialysis services, and home-based dialysis services. The ancillary services consist of integrated kidney care services, physician services supporting integrated kidney care and kidney care initiatives outside of dialysis, clinical research programs, and transplant software business as well as international operations.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan